Resultats de la cerca - Francisco Sánchez-Vega

Refinar resultats
  1. 1
    Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma

    Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma per Marc Ladanyi, Francisco Sánchez-Vega, Marjorie G. Zauderer

    Publicat 2019
    Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  2. 2
    Pan-cancer stratification of solid human epithelial tumors and cancer cell lines reveals commonalities and tissue-specific features of the CpG island methylator phenotype

    Pan-cancer stratification of solid human epithelial tumors and cancer cell lines reveals commonalities and tissue-specific features of the CpG island methylator phenotype per Francisco Sánchez-Vega, Valer Gotea, Gennady Margolin, Laura Elnitski

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Recurrent patterns of DNA methylation in the<i>ZNF154,</i><i>CASP8</i>, and<i>VHL</i>promoters across a wide spectrum of human solid epithelial tumors and cancer cell lines

    Recurrent patterns of DNA methylation in the<i>ZNF154,</i><i>CASP8</i>, and<i>VHL</i>promoters across a wide spectrum of human solid epithelial tumors and cancer cell lines per Francisco Sánchez-Vega, Valer Gotea, Hanna M. Petrykowska, Gennady Margolin, Thomas C. Krivak, Julie A. DeLoia, Daphne W. Bell, Laura Elnitski

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Conditional Selection of Genomic Alterations Dictates Cancer Evolution and Oncogenic Dependencies

    Conditional Selection of Genomic Alterations Dictates Cancer Evolution and Oncogenic Dependencies per Marco Mina, Franck Raynaud, Daniele Tavernari, Elena Battistello, Stéphanie Sungalee, Sadegh Saghafinia, Titouan Laessle, Francisco Sánchez-Vega, Nikolaus Schultz, Elisa Oricchio, Giovanni Ciriello

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    The RNA-editing enzyme ADAR promotes lung adenocarcinoma migration and invasion by stabilizing <i>FAK</i>

    The RNA-editing enzyme ADAR promotes lung adenocarcinoma migration and invasion by stabilizing <i>FAK</i> per Elianna Amin, Yuan Liu, Su Deng, Kay See Tan, Neel P. Chudgar, Marty W. Mayo, Francisco Sánchez-Vega, Prasad S. Adusumilli, Nikolaus Schultz, David R. Jones

    Publicat 2017
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Rb and p53-Deficient Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma Require Skp2 for Survival

    Rb and p53-Deficient Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma Require Skp2 for Survival per George Z. Li, Tomoyo Okada, Youngmi Kim, Narasimhan P. Agaram, Francisco Sánchez-Vega, Yawei Shen, Norifumi Tsubokawa, Jordan Rios, Axel Martin, Mark A. Dickson, Li‐Xuan Qin, Nicholas D. Socci, Samuel Singer

    Publicat 2020
    Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  7. 7
    KMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function

    KMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function per Kinisha Gala, Qing Li, Amit Sinha, Pedram Razavi, M. Dorso, Francisco Sánchez-Vega, Young Rock Chung, Ronald C. Hendrickson, James J. Hsieh, Michael F. Berger, Nikolaus Schultz, Alessandro Pastore, Omar Abdel‐Wahab, Sarat Chandarlapaty

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Tumor Mutation Burden and Efficacy of EGFR-Tyrosine Kinase Inhibitors in Patients with <i>EGFR</i>-Mutant Lung Cancers

    Tumor Mutation Burden and Efficacy of EGFR-Tyrosine Kinase Inhibitors in Patients with <i>EGFR</i>-Mutant Lung Cancers per Michael Offin, Hira Rizvi, Megan Tenet, Ai Ni, Francisco Sánchez-Vega, Bob T. Li, Alexander Drilon, Mark G. Kris, Charles M. Rudin, Nikolaus Schultz, Maria E. Arcila, Marc Ladanyi, Gregory J. Riely, Helena A. Yu, Matthew D. Hellmann

    Publicat 2018
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Oncogenic IDH mutations increase heterochromatin-related replication stress without impacting homologous recombination

    Oncogenic IDH mutations increase heterochromatin-related replication stress without impacting homologous recombination per Juan M. Schvartzman, Grace Forsyth, Henry Walch, Walid K. Chatila, Angelo Taglialatela, Brian J. Lee, Xiaolu Zhu, Steven Gershik, Francesco V. Cimino, Anthony Santella, Kamal Menghrajani, Alberto Ciccia, Richard P. Koche, Francisco Sánchez-Vega, Shan Zha, Craig B. Thompson

    Publicat 2023
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    CDK4/6 or MAPK blockade enhances efficacy of EGFR inhibition in oesophageal squamous cell carcinoma

    CDK4/6 or MAPK blockade enhances efficacy of EGFR inhibition in oesophageal squamous cell carcinoma per Jin Zhou, Zhong Wu, Gabrielle S. Wong, Eirini Pectasides, Ankur K. Nagaraja, Matthew D. Stachler, Haikuo Zhang, Ting Chen, Haisheng Zhang, Jie Bin Liu, Xinsen Xu, Ewa Sicińska, Francisco Sánchez-Vega, Anil K. Rustgi, J. Alan Diehl, Kwok‐Kin Wong, Adam J. Bass

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Effects of Co-occurring Genomic Alterations on Outcomes in Patients with<i>KRAS</i>-Mutant Non–Small Cell Lung Cancer

    Effects of Co-occurring Genomic Alterations on Outcomes in Patients with<i>KRAS</i>-Mutant Non–Small Cell Lung Cancer per Kathryn C. Arbour, Emmett Jordan, Hyunjae R. Kim, Jordan Dienstag, Helena A. Yu, Francisco Sánchez-Vega, Piro Lito, Michael F. Berger, David B. Solit, Matthew D. Hellmann, Mark G. Kris, Charles M. Rudin, Ai Ni, Maria E. Arcila, Marc Ladanyi, Gregory J. Riely

    Publicat 2017
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Early TP53 alterations engage environmental exposures to promote gastric premalignancy in an integrative mouse model

    Early TP53 alterations engage environmental exposures to promote gastric premalignancy in an integrative mouse model per Nilay S. Sethi, Osamu Kikuchi, Gina N. Duronio, Matthew D. Stachler, James M. McFarland, Rubén Ferrer-Luna, Yanxi Zhang, Chunyang Bao, Roderick T. Bronson, Deepa T. Patil, Francisco Sánchez-Vega, Jie-Bin Liu, Ewa Sicińska, Jean‐Bernard Lazaro, Keith L. Ligon, Rameen Beroukhim, Adam J. Bass

    Publicat 2020
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    The Underlying Tumor Genomics of Predominant Histologic Subtypes in Lung Adenocarcinoma

    The Underlying Tumor Genomics of Predominant Histologic Subtypes in Lung Adenocarcinoma per Raul Caso, Francisco Sánchez-Vega, Kay See Tan, Brooke Mastrogiacomo, Jian Zhou, Gregory D. Jones, Bastien Nguyen, Nikolaus Schultz, James G. Connolly, Whitney S. Brandt, Matthew J. Bott, Gaetano Rocco, Daniela Molena, James M. Isbell, Yuan Liu, Marty W. Mayo, Prasad S. Adusumilli, William D. Travis, David R. Jones

    Publicat 2020
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Intraoperative opioid exposure, tumour genomic alterations, and survival differences in people with lung adenocarcinoma

    Intraoperative opioid exposure, tumour genomic alterations, and survival differences in people with lung adenocarcinoma per James G. Connolly, Kay See Tan, Brooke Mastrogiacomo, Joseph Dycoco, Raul Caso, Gregory D. Jones, Patrick J. McCormick, Francisco Sánchez-Vega, Takeshi Irie, Joseph R. Scarpa, Hersh Gupta, Prasad S. Adusumilli, Gaetano Rocco, James M. Isbell, Matthew J. Bott, Gregory W. Fischer, David R. Jones, Joshua S. Mincer

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway

    Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway per Zhiqiang Li, Pedram Razavi, Qing Li, Weiyi Toy, Bo Liu, Christina Ping, Wilson C. Hsieh, Francisco Sánchez-Vega, David Brown, Arnaud Da Cruz Paula, Luc G.T. Morris, Pier Selenica, Emily M. Eichenberger, Ronglai Shen, Nikolaus Schultz, Neal Rosen, Maurizio Scaltriti, Edi Brogi, José Baselga, Jorge S. Reis‐Filho, Sarat Chandarlapaty

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma

    The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma per Ana Banito, Xiang Li, Aimée N. Laporte, Jae‐Seok Roe, Francisco Sánchez-Vega, Chun‐Hao Huang, Amanda R. Dancsok, Katerina Hatzi, Chi-Chao Chen, Darjus F. Tschaharganeh, Rohit Chandwani, Nilgun Tasdemir, Kevin B. Jones, Mario R. Capecchi, Christopher R. Vakoc, Nikolaus Schultz, Marc Ladanyi, Torsten O. Nielsen, Scott W. Lowe

    Publicat 2018
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors

    Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors per Andrew Dunbar, Kelly L. Bolton, Sean M. Devlin, Francisco Sánchez-Vega, Jianjiong Gao, Jodi V. Mones, Jonathan Wills, Daniel J. Kelly, Mirko Farina, Keith B. Cordner, Young Joo Park, Sirish Kishore, Krishna Juluru, Neil M. Iyengar, Ross L. Levine, Ahmet Zehir, Wungki Park, Alok A. Khorana, Gerald A. Soff, Simon Mantha

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Harmonization of Tumor Mutational Burden Quantification and Association With Response to Immune Checkpoint Blockade in Non–Small-Cell Lung Cancer

    Harmonization of Tumor Mutational Burden Quantification and Association With Response to Immune Checkpoint Blockade in Non–Small-Cell Lung Cancer per Natalie I. Vokes, David Liu, Biagio Ricciuti, E. Jimenez-Aguilar, Hira Rizvi, Felix Dietlein, Meng He, Claire A. Margolis, Haitham Elmarakeby, Jeffrey Girshman, Anika E. Adeni, Francisco Sánchez-Vega, Nikolaus Schultz, Suzanne E. Dahlberg, Ahmet Zehir, Pasi A. Jänne, Mizuki Nishino, Renato Umeton, Lynette M. Sholl, Eliezer M. Van Allen, Matthew D. Hellmann, Mark M. Awad

    Publicat 2019
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Therapeutic Implications of Detecting MAPK-Activating Alterations in Cutaneous and Unknown Primary Melanomas

    Therapeutic Implications of Detecting MAPK-Activating Alterations in Cutaneous and Unknown Primary Melanomas per Alexander N. Shoushtari, Walid K. Chatila, Arshi Arora, Francisco Sánchez-Vega, Havish S. Kantheti, Jorge A. Rojas Zamalloa, Penina Krieger, Margaret K. Callahan, Allison Betof Warner, Michael A. Postow, Parisa Momtaz, Suresh Nair, Charlotte E. Ariyan, Christopher A. Barker, Mary S. Brady, Daniel G. Coit, Neal Rosen, Paul B. Chapman, Klaus J. Busam, David B. Solit, Katherine S. Panageas, Jedd D. Wolchok, Nikolaus Schultz

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Clinical and Genomic Characterization of Secondary Rectal Cancer After Radiotherapy for Prostate Cancer

    Clinical and Genomic Characterization of Secondary Rectal Cancer After Radiotherapy for Prostate Cancer per Dana M. Omer, Farheen Shah, Anisha Luthra, Chin‐Tung Chen, Christina I. Lee, Hannah Williams, Henry Walch, Floris S. Verheij, Roni Rosen, Janet Alvarez, Canan Fırat, Georgios Karagkounis, Martin R. Weiser, Maria Widmar, Iris H. Wei, Emmanouil P. Pappou, Garrett M. Nash, J. Joshua Smith, Walid K. Chatila, Paul B. Romesser, Jinru Shia, Philip B. Paty, Julio García‐Aguilar, Francisco Sánchez-Vega

    Publicat 2025
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: